At PM Life Sciences Consulting, we help early-stage life science companies turn great science into real market success. For small biotechs, start-ups, and specialty pharma, the journey from discovery to commercialisation is complex and full of costly pitfalls. We help you navigate that journey with confidence.

Our team provides end-to-end commercialisation support, from shaping the right clinical and medical strategy to preparing for launch, market access, and beyond. Whether you’re UK-based or looking to enter the UK market for the first time, we offer the insight and practical know-how to make your first commercial steps successful.

Our services include:

• UK market entry planning, including affiliate setup, governance, and resourcing

• Commercialisation strategy development - aligning R&D, medical affairs, and market access for launch success

• Interim leadership roles - GM, CMO, Medical Director or Market Access lead to build in-house capability

• Payer and HTA landscape assessments - understanding what UK and EU systems need to fund your product

• Go-to-market and launch readiness planning - including medical communication, stakeholder mapping, and access strategy

We know what investors, payers, and health systems expect from an emerging company. Our support ensures your science is backed by a credible, investable, and executable commercial plan.

Whether you need a trusted UK partner, interim leadership, or end-to-end guidance, we’ll help you bridge the gap between breakthrough innovation and market success.